<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Wang H</submitter><funding>Shandong Science and Technology Promotion Program</funding><funding>National Natural Science Foundation of China (NTFC)</funding><pagination>61</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4966586</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>16</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Peptidylarginine deiminase (PAD) post-translationally converts arginine residues to citrulline residues. Recent studies have suggested that PADI2 (PAD isoform 2), a member of the PAD family, is involved in the tumorigenic process of some tumors, especially breast cancer. However, little is known about the mechanisms of PADI2 in tumorigenesis. This study aimed to elucidate the tumorigenic role and regulatory pathway of PADI2 in breast tumors.&lt;h4>Methods&lt;/h4>The Sequenom MassARRAY and TaqMan genotyping methods were used to investigate the correlation between PADI2 gene SNPs and various tumor risks. PCR array analyses, including cancer pathway finder and signal transduction PCR arrays, were performed to investigate the tumorigenic pathway of PADI2 in the MCF-7 breast cancer</pubmed_abstract><journal>Cancer cell international</journal><pubmed_title>PADI2 gene confers susceptibility to breast cancer and plays tumorigenic role via ACSL4, BINC3 and CA9 signaling.</pubmed_title><pmcid>PMC4966586</pmcid><funding_grant_id>81171990</funding_grant_id><funding_grant_id>2014GSF118135</funding_grant_id><funding_grant_id>81373218</funding_grant_id><funding_grant_id>2014XGA01011</funding_grant_id><funding_grant_id>2012GSF12115</funding_grant_id><pubmed_authors>Zheng Y</pubmed_authors><pubmed_authors>Xu B</pubmed_authors><pubmed_authors>Zhang X</pubmed_authors><pubmed_authors>Wang H</pubmed_authors><pubmed_authors>Zhao Y</pubmed_authors><pubmed_authors>Chang X</pubmed_authors></additional><is_claimable>false</is_claimable><name>PADI2 gene confers susceptibility to breast cancer and plays tumorigenic role via ACSL4, BINC3 and CA9 signaling.</name><description>&lt;h4>Background&lt;/h4>Peptidylarginine deiminase (PAD) post-translationally converts arginine residues to citrulline residues. Recent studies have suggested that PADI2 (PAD isoform 2), a member of the PAD family, is involved in the tumorigenic process of some tumors, especially breast cancer. However, little is known about the mechanisms of PADI2 in tumorigenesis. This study aimed to elucidate the tumorigenic role and regulatory pathway of PADI2 in breast tumors.&lt;h4>Methods&lt;/h4>The Sequenom MassARRAY and TaqMan genotyping methods were used to investigate the correlation between PADI2 gene SNPs and various tumor risks. PCR array analyses, including cancer pathway finder and signal transduction PCR arrays, were performed to investigate the tumorigenic pathway of PADI2 in the MCF-7 breast cancer</description><dates><release>2016-01-01T00:00:00Z</release><publication>2016</publication><modification>2026-06-17T03:12:10.988Z</modification><creation>2019-03-27T02:19:29Z</creation></dates><accession>S-EPMC4966586</accession><cross_references><pubmed>27478411</pubmed><doi>10.1186/s12935-016-0335-0</doi></cross_references></HashMap>